Track topics on Twitter Track topics that are important to you
VANCOUVER, British Columbia, August 11, 2017 /PRNewswire/ --
MYM Nutraceuticals Inc., (OTC: MYMMF), (CSE: MYM) (the "Company" or "MYM") is pleased to announce the "CannaCanada/Weedon BBQ & Open House" August 17, 2017 at the Weedon Arena, 2pm - 7pm, 185 Rue des Érables, Weedon QC.
The public is invited to join key MYM team members and Weedon Community leaders who will be on hand to give a formal update, highlight new partnerships, and answer any questions guests may have regarding the CannaCanada/Weedon project.
Guests will be treated to a BBQ complete with refreshments, music, and surprises. "We are greatly looking forward to personally meeting members of the Weedon community, introducing our local partners, gathering with public officials, and welcoming representatives of the press for an informative and entertaining afternoon at the CannaCanada/Weedon project site", Rob Gietl, CEO for MYM said.
The event will provide an excellent opportunity for guests, press, potential investors and shareholders, to meet face to face with the CannaCanada/Weedon project coordinators and see the site first hand.
For further information regarding the event, please contact Terry Brown at +1-855-696-2261 or via email at email@example.com
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
MYM Investor Relations Contact:
Terry Brown - +1 (855) 696-2261
SOURCE MYM Nutraceuticals Inc.NEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...